Top

Published in:

Open Access 01-12-2022 | COVID-19 Vaccination | Case report

Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report

Authors: Rizaldy Taslim Pinzon, Fillia Kristyawati Haryono, Nikolaus Erik Darmawan, Mia Amelia Mutiara Salikim, Vanessa Veronica

Published in: BMC Neurology | Issue 1/2022

Abstract

Background

Due to a rising number of COVID-19 cases, the Indonesian government implemented public health programs to lower the rate. Since January 2021, one of the government’s primary policies has been the COVID-19 immunization program. Recently, the Moderna messenger ribonucleic acid (mRNA) vaccine is one of the COVID-19 vaccines used in Indonesia. Based on some research, Moderna has possible side effects throughout the body, including neurological symptoms.

Case presentation

We describe a 39-year-old female with uncontrolled hypertension who showed behavioral change, communication difficulty, social withdrawal, and a confused state within 7 days from getting her first dose of the Moderna vaccine. The patient had a history of febrile convulsion in childhood. An increase of neutrophil-to-lymphocyte ratio (16.9) and C-reactive protein level (31.75 mg/L) indicates ongoing inflammation. Head CT scan shows no abnormalities. She received ceftriaxone, citicoline, and methylprednisolone. The patient was discharged on the seventh day and completely recovered 1 week later. This study is the first case report of encephalopathy following the administration of the Moderna COVID-19 vaccine reported in Indonesia up to our knowledge.

Conclusion

Encephalopathy related to the Moderna COVID-19 vaccine should be acknowledged as an adverse effect of the Moderna COVID-19 vaccine.

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16. https://doi.org/10.1056/NEJMoa2035389.CrossRefPubMed

Kadali RAK, Janagama R, Peruru S, Gajula V, Madathala RR, Chennaiahgari N, et al. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol. 2021;93(7):4420–9. https://doi.org/10.1002/jmv.26996.CrossRefPubMedPubMedCentral

Ferenci P. Hepatic encephalopathy. Gastroenterol Rep. 2017;5(2):138–47. https://doi.org/10.1093/gastro/gox013.CrossRef

Tam J, Tran D, Bettinger JA, Moore D, Sauvé L, Jadavji T, et al. Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian immunization monitoring program active (IMPACT) from 1992 to 2012. Vaccine. 2020;38(28):4457–63. https://doi.org/10.1016/j.vaccine.2020.04.035.CrossRefPubMed

Al-Mashdali AF, Ata YM, Sadik N. Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: a case report. Ann Med Surg. 2021;69:102803. https://doi.org/10.1016/j.amsu.2021.102803.CrossRef

Liu BD, Ugolini C, Jha P. Two cases of post-moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus. Cureus. 2021;13(7):e16172. https://doi.org/10.7759/cureus.16172.CrossRefPubMedPubMedCentral

Sriwastava S, Sharma K, Khalid SH, Bhansali S, Shrestha AK, Elkhooly M, et al. COVID-19 vaccination and neurological manifestations: a review of case reports and case series. Brain Sci. 2018;12(3):407. https://doi.org/10.3390/brainsci12030407.CrossRef

Frontera JA, Tamborska AA, Doheim MF, Garcia-Azorin D, Gezegen H, Guekht A, et al. Neurological events reported after COVID-19 vaccines: an analysis of VAERS [published online ahead of print, 2022 mar 2]. Ann Neurol. 2022;91(6):756–71. https://doi.org/10.1002/ana.26339.CrossRefPubMedCentral

Alnefeesi Y, Siegel A, Lui LM, Teopiz KM, Ho R, Lee Y, et al. Impact of SARS-CoV-2 infection on cognitive function: a systematic review. Front Psychiatry. 2021;11:621773. https://doi.org/10.3389/fpsyt.2020.621773.CrossRefPubMedPubMedCentral

10.

Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond. Vaccines (Basel). 2012;9(2):147. https://doi.org/10.3390/vaccines9020147.CrossRef

11.

Mewasingh LD, Chin RFM, Scott RC. Current understanding of febrile seizures and their long-term outcomes. Dev Med Child Neurol. 2020;62:1245–9. https://doi.org/10.1111/dmcn.14642.CrossRefPubMed

Title: Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report
Authors: Rizaldy Taslim Pinzon
Fillia Kristyawati Haryono
Nikolaus Erik Darmawan
Mia Amelia Mutiara Salikim
Vanessa Veronica
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: COVID-19 Vaccination
Febrile Seizure
COVID-19
CT of the Head
Encephalopathy
Published in: BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-022-02834-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Clinical-neuroimaging-pathological relationship analysis of adult onset Neuronal Intranuclear Inclusion Disease (NIID)

Uncommon cause of trigeminal neuritis and central nervous system involvement by herpes labialis: a case report

Clinical characteristics of intracranial aneurysms in elderly patents over 70 years old: a retrospective observational study

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report

Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover study